Literature DB >> 27793842

KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis.

Peng Yuan1,2, Xiao-Hong He1,2, Ye-Fei Rong3, Jing Cao4, Yong Li5, Yun-Ping Hu6, Yingbin Liu6, Dangsheng Li7, Wenhui Lou8, Mo-Fang Liu9,2,4.   

Abstract

KRAS activation occurring in more than 90% of pancreatic ductal adenocarcinomas (PDAC) drives progression and metastasis, but the underlying mechanisms involved in these processes are still poorly understood. Here, we show how KRAS acts through inflammatory NF-κB signaling to activate the transcription factor YY1, which represses expression of the tumor suppressor gene miR-489. In PDAC cells, repression of miR-489 by KRAS signaling inhibited migration and metastasis by targeting the extracellular matrix factors ADAM9 and MMP7. miR-489 downregulation elevated levels of ADAM9 and MMP7, thereby enhancing the migration and metastasis of PDAC cells. Together, our results establish a pivotal mechanism of PDAC metastasis and suggest miR-489 as a candidate therapeutic target for their attack. Cancer Res; 77(1); 100-11. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27793842     DOI: 10.1158/0008-5472.CAN-16-1898

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Autotaxin exacerbates tumor progression by enhancing MEK1 and overriding the function of miR-489-3p.

Authors:  Sudeepti S Kuppa; Wei Jia; Shuying Liu; Ha Nguyen; Susan S Smyth; Gordon B Mills; Kevin K Dobbin; William J Hardman; Mandi M Murph
Journal:  Cancer Lett       Date:  2018-05-31       Impact factor: 8.679

2.  YY1 promotes colorectal cancer proliferation through the miR-526b-3p/E2F1 axis.

Authors:  Zejun Fang; Hua Yang; Dan Chen; Xiaoying Shi; Qinqiu Wang; Chaoju Gong; Xi Xu; Hong Liu; Min Lin; Junxiao Lin; Chengfu Xu; Jimin Shao
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

Review 3.  A step-by-step microRNA guide to cancer development and metastasis.

Authors:  Georgios S Markopoulos; Eugenia Roupakia; Maria Tokamani; Evangelia Chavdoula; Maria Hatziapostolou; Christos Polytarchou; Kenneth B Marcu; Athanasios G Papavassiliou; Raphael Sandaltzopoulos; Evangelos Kolettas
Journal:  Cell Oncol (Dordr)       Date:  2017-07-26       Impact factor: 6.730

4.  The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.

Authors:  Min Chen; Hui Zhang; Zhubing Shi; Yehua Li; Xiaoman Zhang; Ziyang Gao; Li Zhou; Jian Ma; Qi Xu; Jingmin Guan; Yunfeng Cheng; Shi Jiao; Zhaocai Zhou
Journal:  J Biol Chem       Date:  2018-08-02       Impact factor: 5.157

5.  KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.

Authors:  Yoshihisa Tokumaru; Masanori Oshi; Eriko Katsuta; Li Yan; Vikas Satyananda; Nobuhisa Matsuhashi; Manabu Futamura; Yukihiro Akao; Kazuhiro Yoshida; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

Review 6.  MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.

Authors:  Saswati Karmakar; Garima Kaushik; Ramakrishna Nimmakayala; Satyanarayana Rachagani; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Semin Cancer Biol       Date:  2017-12-02       Impact factor: 15.707

Review 7.  Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical In Vivo Models.

Authors:  Ulrich H Weidle; Fabian Birzele; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

8.  Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis.

Authors:  Xu Han; Yuan Fang; Pingping Chen; Yaolin Xu; Wentao Zhou; Yefei Rong; Jian-Ang Li; Wei Chen; Wenhui Lou
Journal:  Cell Cycle       Date:  2021-01-28       Impact factor: 4.534

9.  piRNA-independent function of PIWIL1 as a co-activator for anaphase promoting complex/cyclosome to drive pancreatic cancer metastasis.

Authors:  Feng Li; Peng Yuan; Ming Rao; Chun-Hui Jin; Wei Tang; Ye-Fei Rong; Yun-Ping Hu; Fengjuan Zhang; Tao Wei; Qi Yin; Tingbo Liang; Ligang Wu; Jinsong Li; Dangsheng Li; Yingbin Liu; Wenhui Lou; Shuang Zhao; Mo-Fang Liu
Journal:  Nat Cell Biol       Date:  2020-03-16       Impact factor: 28.824

Review 10.  The Role of Transcription Factor YY1 in the Biology of Cancer.

Authors:  Neeraj Agarwal; Dan Theodorescu
Journal:  Crit Rev Oncog       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.